Are we near to the end of the standard dose of micafungin?

Crit Care. 2018 Jun 5;22(1):149. doi: 10.1186/s13054-018-2068-z.

Authors

Alexander Agrifoglio¹, Lucía Cachafeiro², Eva Herrero², Manuel Sánchez², Abelardo García de Lorenzo²

Affiliations

¹ Department of Intensive Care Medicine, Hospital Universitario La Paz, Paseo de la Castellana 264, 28046, Madrid, Spain. alexander_agrifoglio@yahoo.es.
² Department of Intensive Care Medicine, Hospital Universitario La Paz, Paseo de la Castellana 264, 28046, Madrid, Spain.

No abstract available

Keywords: Candida; Micafungin; Pharmacokinetic.

Publication types

Letter
Comment

MeSH terms

Candida*
Critical Illness
Echinocandins
Humans
Lipopeptides
Micafungin
Obesity, Morbid*

Substances

Echinocandins
Lipopeptides
Micafungin